Columbia US Contrarian Core Equity Private Fund, LLC has made a significant move by filing an amendment to its exempt offering of securities. This filing, dated October 23, 2026, suggests a strategic update that could impact the fund's operations and investor relations.
Columbia US Contrarian Core Equity Private Fund, LLC is classified as an 'other' entity type. The company has been active in the investment management industry, focusing on contrarian investment strategies. The fund has made several filings in recent years, with the most recent prior to this being on October 3, 2025.
The latest filing indicates that the amendment pertains to items related to the Investment Company Act, specifically sections 3(c) and 3(c)(7). However, the filing does not provide specific details on the nature of the changes made. It states, "Effectiveness Date: 2026-10-23," which indicates that the changes are effective immediately.
This amendment could potentially affect investors and stakeholders involved with the fund, as well as other entities within the investment management sector. The filing does not specify what steps will follow this amendment or if there will be any further disclosures.
The filing does not say what happens next.
Company Information
Columbia US Contrarian Core Equity Private Fund, LLC is incorporated in Delaware and has a fiscal year ending on December 31. The company operates out of Boston, Massachusetts, with its mailing and business address both listed as 290 Congress Street, Boston, MA 02110. The contact number provided is 612-678-0121.
Filing Details
This amendment is categorized under Form D/A, indicating it is an amendment to a previously filed Form D. The filing was accepted by the SEC on the same day it was submitted, October 23, 2026, at 15:49:27.
Document Information
The filing includes a primary document in both HTML and XML formats, with the XML document being 12,929 bytes in size. Additionally, there is a complete submission text file available, which is 14,141 bytes.
The filing does not provide insights into the specific changes made to the investment strategy or structure of the fund, nor does it detail the implications of these amendments for current or prospective investors.